Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Triple Body)
TypeName: Business Offer
Category:
Country: United States
Summary: Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD28 antibody are both extended with the scFv fragment from an anti-EGFR antibody. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.https://www.creative-biolabs.com/bsab/symbolsearch-cd28%2520%2526%2520egfr.htm
Description: Recombinant Anti-CD28 x Anti-EGFR Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD28 antibody are both extended with the scFv fragment from an anti-EGFR antibody. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.https://www.creative-biolabs.com/bsab/symbolsearch-cd28%2520%2526%2520egfr.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
